HGH 36UI (Somatropin) – PharmaTech

HGH (Human Growth Hormone), also known as Somatropin or recombinant human growth hormone (rhGH), is a recombinant protein structurally equivalent to the predominant form of naturally occurring human growth hormone.

Somatropin is a 191-amino-acid single-chain polypeptide with a molecular weight of approximately 22.1 kDa. Its structure contains two intramolecular disulfide bonds and is identical in amino-acid sequence to human pituitary growth hormone.

The HGH 36 IU — PharmaTech presentation provides a defined quantity of recombinant somatropin for applications involving research into growth hormone signaling, IGF-1 biology, protein metabolism, lipid metabolism, glucose homeostasis, tissue growth, and cellular regeneration pathways.

OVERVIEW

HGH (Human Growth Hormone), also known as Somatropin or recombinant human growth hormone (rhGH), is a recombinant protein structurally equivalent to the predominant form of naturally occurring human growth hormone.

Somatropin is a 191-amino-acid single-chain polypeptide with a molecular weight of approximately 22.1 kDa. Its structure contains two intramolecular disulfide bonds and is identical in amino-acid sequence to human pituitary growth hormone.

The HGH 36 IU — PharmaTech presentation provides a defined quantity of recombinant somatropin for applications involving research into growth hormone signaling, IGF-1 biology, protein metabolism, lipid metabolism, glucose homeostasis, tissue growth, and cellular regeneration pathways.


MECHANISM OF ACTION

Somatropin exerts its biological effects primarily through interaction with the growth hormone receptor (GHR) located on the surface of target cells.

Binding of GH to its receptor initiates intracellular signaling pathways that regulate the expression and activity of multiple growth- and metabolism-related proteins.

A major component of its biological activity occurs through stimulation of IGF-1 (Insulin-like Growth Factor-1) production, particularly in the liver, while other effects result directly from GH receptor activation.

Key signaling mechanisms include:

  • Growth hormone receptor activation
  • JAK2/STAT signaling
  • Increased hepatic IGF-1 production
  • IGF-1 receptor signaling
  • Stimulation of protein synthesis
  • Regulation of lipid metabolism
  • Modulation of glucose metabolism
  • Stimulation of connective-tissue and skeletal pathways

The physiological actions of somatropin therefore involve both direct GH receptor signaling and indirect IGF-1-mediated signaling.


KEY BENEFITS

Research involving recombinant human growth hormone has focused on:

  • Growth hormone signaling
  • IGF-1 production
  • Protein synthesis
  • Nitrogen metabolism
  • Lipid metabolism
  • Lipolytic activity
  • Glucose homeostasis
  • Skeletal growth
  • Connective-tissue biology
  • Cellular growth and differentiation
  • Muscle and tissue metabolism
  • Endocrine physiology

RESEARCH AREAS

Growth Hormone Biology

Investigation of GH receptor activation, downstream signaling, endocrine regulation, and physiological growth pathways.

IGF-1 Signaling

Somatropin is extensively studied for its ability to stimulate hepatic and local IGF-1 production and the subsequent activation of IGF-1-dependent pathways.

Protein Metabolism

Research examines GH-mediated stimulation of amino-acid uptake, protein synthesis, and nitrogen retention.

Lipid Metabolism

Somatropin has direct metabolic effects involving adipose tissue and lipid mobilization, including stimulation of lipolysis.

Glucose Metabolism

Research investigates the interaction between GH signaling, hepatic glucose production, insulin sensitivity, and glucose homeostasis.

Skeletal Biology

Growth hormone and IGF-1 play central roles in chondrocyte activity, bone growth, and skeletal development.

Muscle Biology

Research includes GH/IGF-1 signaling in skeletal muscle, protein turnover, tissue growth, and metabolic regulation.

Regenerative Biology

GH and IGF-1 pathways are studied in relation to connective tissue, extracellular matrix regulation, cellular proliferation, and tissue remodeling.


SCIENTIFIC EVIDENCE

Somatropin is one of the most extensively characterized peptide hormones in modern endocrinology.

Recombinant somatropin has the same amino-acid sequence as endogenous human growth hormone and has been studied extensively in clinical and experimental settings.

Its biological effects are mediated through the growth hormone receptor and downstream signaling involving IGF-1, protein synthesis, lipid metabolism, glucose metabolism, and tissue growth.

Clinical pharmacology studies demonstrate measurable increases in circulating IGF-1 following administration of somatropin, with IGF-1 serving as an important pharmacodynamic biomarker of GH activity.

Because of its extensive characterization, somatropin provides a well-established experimental model for investigating GH/GHR/IGF-1 signaling and endocrine regulation.


MOLECULAR PROFILE

Property Specification
Molecule Somatropin
Common Name Human Growth Hormone (HGH)
Alternative Names rhGH, Recombinant Human Growth Hormone
Protein Class Recombinant peptide hormone
Amino Acids 191
Molecular Formula C₉₉₀H₁₅₂₈N₂₆₂O₃₀₀S₇
Molecular Weight ~22,124 Da
Primary Receptor Growth Hormone Receptor (GHR)
Major Secondary Mediator IGF-1
Structural Type Single-chain polypeptide
Disulfide Bonds 2 intramolecular disulfide bonds
Biological Class Growth hormone
Presentation 36 IU

Somatropin consists of 191 amino-acid residues with two intramolecular disulfide bonds and a molecular mass of approximately 22.1 kDa.


PHARMACOKINETIC & PHARMACODYNAMIC PROFILE

Pharmacokinetic Profile

Following subcutaneous administration, somatropin is absorbed into systemic circulation and produces measurable increases in circulating GH and IGF-1.

Pharmacokinetic characteristics vary according to formulation, route of administration, dose, and individual physiological factors.

In a clinical pharmacology study of subcutaneous somatropin, peak serum concentrations occurred several hours after administration, with an absolute bioavailability of approximately 70% for the studied formulation.

Somatropin undergoes systemic metabolism and clearance through multiple pathways, including hepatic and renal processes.

Pharmacodynamic Profile

The principal signaling cascade can be summarized as:

Somatropin → GHR activation → JAK/STAT signaling → IGF-1 production → IGF-1 receptor activation → Cellular growth & metabolic signaling

Direct GH receptor effects additionally influence:

  • Lipolysis
  • Protein synthesis
  • Glucose metabolism
  • Amino-acid utilization
  • Connective-tissue metabolism
  • Skeletal biology

RESEARCH HIGHLIGHTS

Recombinant Human Growth Hormone

Somatropin is structurally equivalent in amino-acid sequence to endogenous human growth hormone and has been extensively characterized through recombinant biotechnology.

GHR Signaling

The growth hormone receptor represents the primary molecular interface through which somatropin initiates intracellular signaling.

IGF-1 Axis

The GH–IGF-1 axis represents one of the principal endocrine pathways involved in somatropin biology.

Protein Synthesis

GH/IGF-1 signaling plays a major role in regulation of protein synthesis and tissue growth.

Lipid Metabolism

Somatropin has direct effects on adipose tissue and lipid mobilization, making GH signaling an important area of metabolic research.

Glucose Regulation

The interaction between GH signaling, hepatic glucose production, insulin sensitivity, and IGF-1 represents an important area of endocrine research.

Skeletal & Tissue Biology

The GH/IGF-1 axis is extensively studied in relation to skeletal development, connective tissue, cellular proliferation, and tissue remodeling.


TECHNICAL SPECIFICATIONS

Specification HGH 36 IU — PharmaTech
Product Name HGH 36 IU
Active Molecule Somatropin
Alternative Name Recombinant Human Growth Hormone
Protein Length 191 amino acids
Molecular Weight ~22.1 kDa
Molecular Formula C₉₉₀H₁₅₂₈N₂₆₂O₃₀₀S₇
Primary Receptor Growth Hormone Receptor
Major Mediator IGF-1
Structural Type Single-chain recombinant protein
Disulfide Bonds 2
Physical Form Lyophilized protein
Potency 36 IU
Purity [PharmaTech specification]
Presentation [PharmaTech specification]

STORAGE & HANDLING

  • Store the lyophilized material under controlled conditions according to the applicable PharmaTech specification.
  • Protect from excessive heat, moisture, and direct light.
  • Maintain the original container sealed until laboratory handling.
  • Avoid unnecessary agitation of the reconstituted protein.
  • Minimize repeated freeze–thaw exposure.
  • Handle the material using appropriate laboratory procedures.
  • Reconstituted material should be stored and handled according to the applicable PharmaTech product specification.